Design, synthesis, and antiviral evaluation of 2-substituted 4,5- dichloro- and 4,6-dichloro-1-β-D-ribofuranosylbenzimidazoles as potential agents for human cytomegalovirus infections

Journal of Medicinal Chemistry

Volumn 40, Issue 5, 1997, Pages 802-810

  Zou, Ruiming ^a   Drach, John C ^b   Townsend, Leroy B ^b  

^a GILEAD SCIENCES   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

4,5 DICHLORO 1 BETA D RIBOFURANOSYLBENZIMIDAZOLE DERIVATIVE; 4,6 DICHLORO 1 BETA D RIBOFURANOSYLBENZIMIDAZOLE DERIVATIVE; ANTIVIRUS AGENT; BENZIMIDAZOLE DERIVATIVE; UNCLASSIFIED DRUG;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANIMAL CELL; ANTIVIRAL ACTIVITY; ARTICLE; CYTOMEGALOVIRUS INFECTION; DRUG DESIGN; DRUG SYNTHESIS; HERPES SIMPLEX VIRUS 1; HUMAN; HUMAN CELL; HUMAN CYTOMEGALOVIRUS; INFECTION RISK; NONHUMAN;

ANTIVIRAL AGENTS; BENZIMIDAZOLES; CELL DIVISION; CELL LINE; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; DRUG DESIGN; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; MOLECULAR STRUCTURE; RIBONUCLEOSIDES; SIMPLEXVIRUS;

EID: 0031048289     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm960533b     Document Type: Article

References (39)

1. Zou, R.; Drach, J. C.; Townsend, L. B. Synthesis and Antiviral Activity of 1-β-D-Ribofuranosyl-2,4,6-trichlorobenzimidazole. A part of this work has been presented at the 199th ACS national meeting, Boston, MA, Apr 22, 1990.
2. Jacobson, M. A.; Mills, J. Serious Cytomegalovirus Disease in the Acquired Immunodeficiency Syndrome (AIDS), Clinical Findings, Diagnosis, and Treatment. Ann. Intern. Med. 1988, 108, 585-594.
3. Alford, C. A.: Britt, W. J. Cytomegalovirus. In the Human Herpesviruses; Roizman, B., Whitley, R. J., Lopez, C., Eds.; Raven Press: New York, 1993; pp 227-255.
4. Meyers, J. D.; Flournoy, N.; Thomas, E. D. Risk Factors for Cytomegalovirus Infection after Human Marrow Transplantation. J. Infect. Dis. 1986, 153, 478-488.
5. Bombi, J. A.; Cardesa, A.; Llebaria, C.; Rives, A.; Carreras, E.; Granena, A.; Jimenez de Anta, M. T. Main Autopsy Findings in Bone Marrow Transplant Patients. Arch. Pathol. Lab. Med. 1987, 111, 125-129.
6. Glenn, J. Cytomegalovirus Infections Following Renal Transplantation. Rev. Infect. Dis. 1981, 3, 1151-1178.
7. Rytel, M. W.; Kauffman, H. M. Clinical Efficacy of Adenine Arabinoside in Therapy of Cytomegalovirus Infections in Renal Allograft Recipients. J. Infect. Dis. 1976, 133, 202-205.
8. Wade, J. C.; Hintz, M.; McGuffin, R. W.; Springmeyer, S. C.; Connor, J. D.; Meyers, J. D. Treatment of Cytomegalovirus Pneumonia with High-Dose Acyclovir. Am. J. Med. 1982, 73, Suppl. 1A, 249-256.
9. Meyers, J. D.; McGuffin, R. W.; Bryson, Y. J.; Cantell, K.; Thomas, E. D. Treatment of Cytomegalovirus Pneumonia after Marrow Transplant with Combined Vidarabine and Human Leukocyte Interferon. J. Infect. Dis. 1982, 146, 80-84.
10. Wade, J. C.; McGuffin, R. W.; Springmeyer, S. C.; Newton, B.; Singer, J. W.; Meyers, J. D. Treatment of Cytomegalovirus Pneumonia with High-Dose Acyclovir and Human Leukocyte Interferon. J. Infect. Dis. 1983, 148, 557-562.
11. (a) Morris, D. J. Antiviral Chemotherapy for Cytomegalovirus Disease. J. Antimicrob. Chemother. 1988, 21, 519-522.
12. (b) Skolnik P. R.; Hirsch, M. S. Therapy and Prevention of Cytomegalovirus Infections. In Clinical Use of Antiviral Drugs; DeClercq, E., Ed.; Martinus Nijhoff Publishing: Norwell, 1988; pp 159-194.
13. Faulds, D.; Heel, R. C. Ganciclovir. A Review of its Antiviral Activity, Pharmacokinetic Properties and Therapeutic Efficacy in Cytomegalovirus Infections. Drugs 1990, 39, 597-638.
14. Chrisp, P.; Clissold, S. P. Foscarnet. A Review of its Antiviral Activity, Pharmacokinetic Properties and Therapeutic use in Immunocompromised Patients with Cytomegalovirus Retinitis. Drugs 1991, 41, 104-129.
15. (a) Kirsch, L. S.; Arevalo J. F.; De Clercq, E.; Chavez de la Paz, E.; Munguia, D.; Garcia, R.; Freeman, W. R. Phase VII study of intravitreal cidofovir for the treatment of cytomegalovirus retinitis in patients with the acquired immunodeficiency syndrome. Am. J. Ophthalmol. 1995, 119, 466-476.
16. (b) Polis, M. A.; Spooner, K. M.; Baird, B. F.; Manischewitz, J. F.; Jaffe, H. S.; Fisher. P. E.; Falloon, J.; Davey, R. T. Jr.; Kovacs, J. A.; Walker, R. E.; et al. Anticytomegaloviral activity and safety of cidofovir in patients with human immunodeficiency virus infection and cytomegalovirus viruria. Antimicrob. Agents Chemother. 1995 39, 882-886.
17. Field, A. K.; Biron, K. K. "The End of Innocence" Revisited: Resistance of Herpesviruses to Antiviral Drugs. Clin. Microbiol. Rev. 1994, 7, 1-13.
18. Townsend, L. B.; Revankar, G. R. Benzimidazole Nucleosides, Nucleotides, and Related Derivatives. Chem. Rev. 1970, 70 389-438.
19. (a) Townsend, L. B.; Devivar, R. V.; Turk, S. R.; Nassiri, M. R.; Drach, J. C. Design, Synthesis and Antiviral Activity of Certain 2,5,6-trihalo-1-(β-D-ribofuranosyl)-benzimidazoles. J. Med. Chem. 1995, 38, 4098-4105.
20. (b) Townsend, L. B. Benzimidazole Ribonucleosides: Design, Synthesis, and Evaluation of 2,5,6-Trichloro-1-(β-D-ribofuranosyl)benzimidazole (TCRB), 2-Bromo-5,6-dichloro-1-(β-D-ribofuranosyl)benzimidazole (BDCRB), and Some Structurally Related Analogs as Agents for Human Cytomegalovirus Infections. Fifth International Conference on Antiviral Research, Vancouver, B.C., Canada, 8-13 March, 1992.
21. (c) Drach J. C.; Townsend, L. B.; Nassiri, M. R.; Turk, S. R.; Coleman, L. A.; Devivar, R. V.; Genzlinger, G; Kreske, E. D.; Renau, T. E.; Westerman, A. C.; Shipman, C., Jr.; Biron, K. K.; Dornsife, R.; Kern, E. R. Benzimidazole Ribonucleosides: A New Class of Antivirals with Potent and Selective Activity Against Human Cytomegalovirus. Fifth International Conference on Antiviral Research, Vancouver, B.C., Canada, 8-13 March, 1992.
22. Nassiri, M. R.; Emerson, S. G.; Townsend, L. B.; Drach, J. C.; Taichman, R. S. Comparison of Benzimidazole Nucleosides and Ganciclovir on the In Vitro proliferation and Colony Formation of Human Bone Marrow Progenitor Cells. Br. J. Haematol. 1996, 93, 273-279.
23. (a) Underwood, M. R.; Biron, K. K.; Hemphill, M. L.; Miller, T. J.; Stanat, S.C.; Dornsife, R. E.; Drach, J. C.; Townsend, L. B.; Edwards, C. A.; Harvey, R. J. High Molecular Weight HCMV DNA Does Not Properly Mature in the Presence of 2-Bromo-5,6-dichloro-1-β-D-ribofuranosylbenzimidazole (BDCRB). Herpesvirus Workshop, Pittsburgh, PA, July, 1993.
24. (b) Underwood, M. R.; Stanat, S. C.; Drach, J. C.; Harvey R. J.; Biron, K. K. Inhibition of HCMV DNA Processing by a New Class of Anti-HCMV Compounds is Mediated Through the UL89 Gene Product. Herpesvirus Workshop, Vancouver, B.C., August 1994.
25. Ricci A.; Vivarelli, P. Benzimidazoles II. Effect of Benzene Nucleus substituents on the Nucleophilic Reactivity of Some 2-Chlorobenzimidazoles. Gazz. Chim. Ital. 1967, 97, 750-757. Chem. Abstr. 1967, 67, 108597x.
26. Ricci A.; Vivarelli, P. Benzimidazoles II. Effect of Benzene Nucleus substituents on the Nucleophilic Reactivity of Some 2-Chlorobenzimidazoles. Gazz. Chim. Ital. 1967, 97, 750-757. Chem. Abstr. 1967, 67, 108597x.
27. Rochling, H.; Frasca, E.; Buchel, K. H. Synthesen von Benzimidazolonen and Polychlorierten Benzimidazolen. Z. Naturforsch. 1970, 25b, 954-960.
28. Mandel, L. R.; Porter, C. C.; Kuehl, F. A., Jr.; Jensen, N. P.; Schmitt, S. M.; Windholz, T. B.; Beattie, T. R.; Garty, J. A.; Christensen, B. G.; Shen, T. Y. Inhibition of Adrenal Phenethanolamine N-Methyltransferase by Substituted Benzimidazoles. J. Med. Chem. 1970, 13, 1043-1047.
29. Kawashima, E.; Gupta, P. K.; Devivar, R. V.; Townsend, L. B. Synthesis of a Precursor for 2-Substituted 5,6-Dichlorobenzimidazoles. In Nucleic Acid Chemistry, Improved and New Synthetic Procedures, Methods and Techniques; Townsend, L. B., Tipson, R. S., Eds.; Wiley-Interscience: New York, 1991; Vol. 4, pp 24-26.
30. Scott, R. M.; Tomlinson, M. Some Dichloro- and Dibromo-derivatives of 1:2:3:4-Tetrahydrophenazine and cis-1:2:3:4:5:10: 11:12-Octahydrophenazine. J. Chem. Soc. 1959, 417-420.
31. Baker, B. R.; Joseph, J. P.; Schaub, R. E.; Williams, J. H. Puromycin Synthetic Studies. V. 6-Dimethylamino-9-(2′-Acetamino-β-D-Glucopyranosyl)purine. J. Org. Chem. 1954, 19, 1786-1792.
32. Townsend, L. B. Nuclear Magnetic Resonance Spectroscopy in the Study of Nucleic Acid Components and Certain Related Derivatives. In Synthetic Procedures in Nucleic Acid Chemistry Vol. 2, Physical and Physicochemical Aids in Characterization and in Determination of Structure; Zorbach, W. W., Tipson, R. S., Eds.; Wiley-Interscience: New York, 1973; pp 267-398.
33. Rosemeyer, H.; Toth, G.; Seela, F. Assignment of Anomeric Configuration of D-Ribo, Arabino-, 2′-Deoxyribo-, and 2′,3′-Dideoxyribonucleosides by NOE Difference Spectroscopy. Nucleosides Nucleotides 1989, 8, 587-597.
34. Toth, G.; Rosemeyer, H.; Seela, F. Unambiguous Assignment of Anomeric Configuration of Nucleosides by NOE-Difference Spectroscopy. Nucleosides Nucleotides 1989, 8, 1091-1092.
35. Devivar, R. V.; Kawashima, E.; Revankar, G. R.; Breitenbach, J. M.; Drach, J.C.; Townsend, L. B. Benzimidazole Ribonucleosides: Design, Synthesis and Antiviral Evaluation of Certain 2-alkylthio-5,6-dichloro-1-(β-D-ribofuranosyl)benzimidazoles. J. Med. Chem. 1994, 37, 2942-2949.
36. Turk, S. R.; Shipman, C., Jr.; Nassiri, M. R.; Genzingler, G.; Krawczyk, S. H.; Townsend, L. B.; Drach, J. C. Pyrrolo[2,3-dlpyrimidine Nucleosides as Inhibitors of Human Cytomegalovirus. Antimicrob. Agents Chemother. 1987, 31, 544-550.
37. Prichard, M. N.; Turk, S. R.; Coleman, L. A.; Engelhardt, S. L.; Shipman, C., Jr.; Drach, J. C. A Microtiter Virus Yield Reduction Assay for The Evaluation of Antiviral Compounds Against Human Cytomegalovirus and Herpes Simplex Virus. J. Virol. Methods 1990, 28, 101-106.
38. Prichard, M. N.; Shipman, C., Jr. A Three-Dimensional Model To Analyze Drug-Drug Interactions. Antiviral Res. 1990, 14, 181-206.
39. Prichard, M. N.; Prichard, L. E.; Baguley, W. A.; Nassiri, M. R.; Shipman, C., Jr. Three Dimensional Analysis of the Synergistic Cytotoxicity of Ganciclovir and Zidovudine. Antimicrob. Agents Chemother. 1991, 35, 1060-1065.